ATE408020T1 - Verfahren zur herstellung von faktor vii - Google Patents

Verfahren zur herstellung von faktor vii

Info

Publication number
ATE408020T1
ATE408020T1 AT99955836T AT99955836T ATE408020T1 AT E408020 T1 ATE408020 T1 AT E408020T1 AT 99955836 T AT99955836 T AT 99955836T AT 99955836 T AT99955836 T AT 99955836T AT E408020 T1 ATE408020 T1 AT E408020T1
Authority
AT
Austria
Prior art keywords
factor vii
producing factor
cells
producing
fvii
Prior art date
Application number
AT99955836T
Other languages
English (en)
Inventor
Helle Woeldike
Finn Wiberg
Lars Nielsen
Original Assignee
Novo Nordisk Healthcare Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk Healthcare Ag filed Critical Novo Nordisk Healthcare Ag
Application granted granted Critical
Publication of ATE408020T1 publication Critical patent/ATE408020T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6437—Coagulation factor VIIa (3.4.21.21)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21021—Coagulation factor VIIa (3.4.21.21)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT99955836T 1998-11-06 1999-11-05 Verfahren zur herstellung von faktor vii ATE408020T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DKPA199801436 1998-11-06
DKPA199801439 1998-11-09
US10806598P 1998-11-12 1998-11-12
PCT/DK1999/000607 WO2000028065A1 (en) 1998-11-06 1999-11-05 Method for the production of fvii

Publications (1)

Publication Number Publication Date
ATE408020T1 true ATE408020T1 (de) 2008-09-15

Family

ID=27221287

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99955836T ATE408020T1 (de) 1998-11-06 1999-11-05 Verfahren zur herstellung von faktor vii

Country Status (8)

Country Link
US (2) US6329176B1 (de)
EP (1) EP1127154B1 (de)
JP (1) JP4463988B2 (de)
AT (1) ATE408020T1 (de)
AU (1) AU1262900A (de)
DE (1) DE69939548D1 (de)
ES (1) ES2315022T3 (de)
WO (1) WO2000028065A1 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7247708B2 (en) 1997-10-23 2007-07-24 Regents Of The University Of Minnesota Modified vitamin K-dependent polypeptides
US6747003B1 (en) 1997-10-23 2004-06-08 Regents Of The University Of Minnesota Modified vitamin K-dependent polypeptides
SK782002A3 (en) 1999-07-21 2003-08-05 Lexigen Pharm Corp FC fusion proteins for enhancing the immunogenicity of protein and peptide antigens
RU2278123C2 (ru) 2000-02-11 2006-06-20 Максиджен Холдингз Лтд. Молекулы, подобные фактору vii или viia
US7812132B2 (en) 2000-04-28 2010-10-12 Regents Of The University Of Minnesota Modified vitamin K-dependent polypeptides
US7220837B1 (en) 2000-04-28 2007-05-22 Regents Of The University Of Minnesota Modified vitamin K-dependent polypeptides
US20030211094A1 (en) 2001-06-26 2003-11-13 Nelsestuen Gary L. High molecular weight derivatives of vitamin k-dependent polypeptides
DE60137950D1 (de) 2000-10-02 2009-04-23 Novo Nordisk Healthcare Ag Verfahren zur herstellung vitamin-k-abhängiger proteine
HUP0402158A2 (hu) 2001-10-02 2005-01-28 Novo Nordisk Health Care Ag Rekombináns fehérjék előállítási eljárása eukarióta sejtekben
SI1499719T1 (sl) 2002-04-30 2011-03-31 Bayer Healthcare Llc Polipeptidne variante faktorja VII ali VIIa
DK2085470T3 (da) 2003-03-20 2012-08-06 Bayer Healthcare Llc FVII- eller FVIIa-varianter
WO2004100882A2 (en) * 2003-05-06 2004-11-25 Syntonix Pharmaceuticals, Inc. Inhibition of drug binding to serum albumin
EP2298347B1 (de) 2003-05-06 2015-09-30 Biogen Hemophilia Inc. Chimäre Proteine mit Gerinnungsfaktor zur Behandlung von hämostatischen Erkrankungen
TWI353991B (en) 2003-05-06 2011-12-11 Syntonix Pharmaceuticals Inc Immunoglobulin chimeric monomer-dimer hybrids
US7348004B2 (en) 2003-05-06 2008-03-25 Syntonix Pharmaceuticals, Inc. Immunoglobulin chimeric monomer-dimer hybrids
CN1839203B (zh) 2003-06-19 2011-11-16 拜耳医药保健有限公司 因子VII或VIIa的GLA结构域变体
ATE547519T1 (de) 2003-09-09 2012-03-15 Novo Nordisk Healthcare Ag Gerinnungsfaktor-vii-polypeptide
US8461115B2 (en) 2006-03-16 2013-06-11 Stellaris Pharmaceuticals Aps Methods for local treatment with factor VII
NZ597022A (en) 2009-06-09 2014-05-30 Prolong Pharmaceuticals Llc Hemoglobin compositions
US10172949B2 (en) 2009-06-09 2019-01-08 Prolong Pharmaceuticals, LLC Hemoglobin compositions
US10172950B2 (en) 2009-06-09 2019-01-08 Prolong Pharmaceuticals, LLC Hemoglobin compositions
RU2448160C1 (ru) * 2010-11-11 2012-04-20 Закрытое акционерное общество "ГЕНЕРИУМ" РЕКОМБИНАНТНАЯ ПЛАЗМИДНАЯ ДНК pAP271, КОДИРУЮЩАЯ ПОЛИПЕПТИД ФАКТОРА VII СВЕРТЫВАЕМОСТИ КРОВИ ЧЕЛОВЕКА, И ЛИНИЯ КЛЕТОК Mesocricetus auratus ВНК 21 k.13 (2H7) - ПРОДУЦЕНТ РЕКОМБИНАНТНОГО ФАКТОРА VII СВЕРТЫВАЕМОСТИ КРОВИ ЧЕЛОВЕКА
AU2014228938B2 (en) 2013-03-15 2019-05-02 Bioverativ Therapeutics Inc. Factor IX polypeptide formulations
BR102015012334A2 (pt) 2015-05-27 2016-11-29 Fundação Hemoct De Ribeirão Preto Fundherp processo de produção do fator vii de coagulação sanguínea e fator vii de coagulação sanguínea

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5516650A (en) * 1985-06-27 1996-05-14 Zymogenetics, Inc. Production of activated protein C
CA1340740C (en) * 1987-12-08 1999-09-14 Eileen R. Mulvihill Co-expression in eukaryotic cells
ATE158816T1 (de) * 1990-11-26 1997-10-15 Genetics Inst Expression von pace in wirtszellen und verfahren zu dessen verwendung
ES2107520T3 (es) * 1991-12-16 1997-12-01 Ciba Geigy Ag Endoproteasa dibasica recombinante situada en el reticulo endoplasmico y usos de la misma.

Also Published As

Publication number Publication date
EP1127154B1 (de) 2008-09-10
JP4463988B2 (ja) 2010-05-19
US6329176B1 (en) 2001-12-11
DE69939548D1 (de) 2008-10-23
ES2315022T3 (es) 2009-03-16
EP1127154A1 (de) 2001-08-29
WO2000028065A1 (en) 2000-05-18
US20020160458A1 (en) 2002-10-31
AU1262900A (en) 2000-05-29
JP2003523168A (ja) 2003-08-05

Similar Documents

Publication Publication Date Title
ATE408020T1 (de) Verfahren zur herstellung von faktor vii
DE69637867D1 (de) Verfahren zur Kontrollierung der Sialylierung von durch Säugetierzellkultur hergestellten Proteinen
ATE265538T1 (de) Verfahren zur sekretion thrombopoitin polypeptide
DE69939945D1 (de) Verfahren zur isolierung von stammzellen
DK1137808T3 (da) Fremgangsmåde til fremstilling af rekombinante celler
DE69734936D1 (de) Wirtszellen und methoden für die produktion von proteinen
ATE383417T1 (de) Produktion lymphoider gewebsspezifischer zellen von hämatopoietischen vorläuferzellen in einem dreidimensionalen system
ATE397488T1 (de) Vorrichtung zur herstellung von liposomen
DE69720026T2 (de) Verfahren zur herstellung von d-aminosäuren durch direkte gärung
ATA165999A (de) Medium zur protein- und serumfreien kultivierung von zellen
DE60331226D1 (de) Verfahren und dna-konstrukte zur produktion von polypeptiden mit hoher ausbeute
ATE363806T1 (de) Verfahren und vorrichtung zur bereitstellung von nachrichtenorientierten sprachkommunikationen zwischen mehreren partnern
ATE430807T1 (de) Verfahren zur kultivierung von circovirus
WO2003105252A3 (en) CERAMIC ANODES AND PROCESS FOR PRODUCING THE SAME
ATE338138T1 (de) Verfahren zur proteinproduktion in pflanzen
DE69030765D1 (de) Medien zur zellzucht und verfahren dazu
ATE309267T1 (de) Methode zur proliferation und differenzierung von b-zellen und verwendungen dafür
PT1200561E (pt) Clone celular recombinante estavel, sua producao e utilizacao
GB0208041D0 (en) Method of culturing animal cells
ATE248855T1 (de) Methoden zur herstellung von rekombinanten peptiden mit einer geringen menge von trisulfiden
DE69933699D1 (de) Verfahren zur produktion rekombinanter proteine in säugetierzellen durch co-expression mit fetuin
WO2002022157A3 (en) Injectable hybrid matrix mixtures
DE60024596D1 (de) Sequenzen zur verbesserung der sekretionseffizienz von nicht-sekretierten proteinen in säugetier- und insektenzellen
ATE292189T1 (de) Verfahren zur enzymatischen kinetischen trennung von 3-phenylglycidsäure durch umesterung mittels aminoalkoholen
TR199801514A2 (xx) N-Piruvil-L-Prolin �retimi i�in y�ntem.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties